It’s Directional

Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totaling more than $1 billion.

The company’s experimental vaccine is currently in early-stage human trials and is expected to begin late-stage human trials in September, executives have previously said. The deal gives the U.S. the option to order an additional 200 million doses, according to the announcement.

This is really all that matters. Just about everything else is noise, because the virus being prevented will change it all. Therefore, if you just think and focus on this one thing, you’re saving yourself a lot of time.

There will now be a steady procession of vaccine related news each week into the actual FDA approval. My bet is that the first vaccine is approved this fall, before the election. I don’t know anything about vaccines but I know all I need to know about people and incentives.

Batches are already being produced for several of the leading vaccine candidates. Maybe more than one gets approved this year. You don’t need enough doses for everyone. You just need enough for people to feel like the problem has a solution.

The economy is going to roar if this happens. Roar. The stock market is sniffing this possibility out. So are the metals and other commodity prices.

If you’re hearing people saying boring, predictable things like “It’s going to be a long time before things get back to where they were blah blah blah” they’re absolutely clueless about how this stuff works. It’s not about the degree of recovery for the stock market, or some now-forgotten high watermark for a particular economic benchmark. Nobody gives a f*** about that. It’s DIRECTIONAL. That’s all that ever concerns the stock market. Which way are we going and at what speed? 

Well, on a vaccine approval, we’re getting our lives back and all the activity around you is going up. And the speed will be breakneck. We just need to get through the air pockets between now and then.


Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion (CNBC)


This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here:

Please see disclosures here.

What's been said:

Discussions found on the web
  1. bitcoin era news commented on Sep 25

    … [Trackback]

    […] Find More on that Topic: […]

  2. Devops commented on Nov 19

    … [Trackback]

    […] Read More to that Topic: […]

  3. Power to Choose Texas commented on Jan 08

    … [Trackback]

    […] Read More Information here to that Topic: […]

  4. Digital Transformation commented on Jan 16

    … [Trackback]

    […] Info to that Topic: […]